- A plain language summary of results from the FLAURA2 study: Initial (…
Number of the records: 1  

A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC

  1. SYS0203559
    LBL
      
    00000naa--2200000-a-4500
    005
      
    20250607183002.0
    008
      
    250401s2025----xo-----e------------eng--
    040
      
    $a BA006 $b slo
    041
    0-
    $a eng
    044
      
    $a xo $c SK
    245
    12
    $a A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC / $c Planchard D., Andrasina I. ... [et al.]
    500
      
    $a Future Oncol. 2025 Feb 24, 217:115255
    650
    12
    $7 sllk_us_auth*d002289 $a karcinóm pľúc, nemalobunkový $2 mesh
    650
    22
    $7 sllk_us_auth*d066246 $a receptory erbB $2 mesh
    650
    22
    $7 sllk_us_auth*d000074322 $a antineoplastiká imunologické $2 mesh
    650
    22
    $7 sllk_us_auth*d000092004 $a inhibítory tyrozínkináz $2 mesh
    650
    22
    $7 sllk_us_auth*d000068456 $a štúdie klinické ako téma $2 mesh
    653
    2-
    $a osimertinib
    653
    2-
    $a štúdia FLAURA2
    653
    2-
    $a 1. línia liečby
    700
    1-
    $7 sllk_us_auth*p0052935 $a Andrašina, Igor, $d 1955- $u Oddelenie klinickej onkológie Východoslovenského onkologického ústavu, a. s., Košice $4 ant
    710
    2-
    $7 sllk_us_auth*0012742 $a Redakcia Onkológia $4 adp
    773
    0-
    $7 nnas $w sllk_us_cat*0203499 $t Onkológia $x 1336-8176 $d Bratislava : SOLEN, 2025 $g Roč. 20, č. 1 (2025), s. 63-64
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.